分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

A novel role for YPEL2 in mediating endothelial cellular senescence via the p53/p21 pathway

Jian-Xiong Xu, Mao-Lin Tang, Zhi-Feng Lu, Yu Song, Ke-Lan Zhang, Run-Chao He, Xiang-Na Guo, Yun-Qi Yuan, Xiaoyan Dai, Xin Ma

Journal:MECHANISMS OF AGEING AND DEVELOPMENT

IF:5.3

DOI:10.1016/j.mad.2023.111803

PMID:36963468

Published:2023-03-22

research field:分子生物学心血管生物学衰老研究细胞衰老

Abstract

Yippee-like 2 (YPEL2) is expressed in tissues and organs enriched in vascular networks, such as heart, kidney, and lung. However, the roles of YPEL2 in endothelial cell senescence and the expression of YPEL2 in atherosclerotic plaques have not yet been investigated. Here, we report the essential role of YPEL2 in promoting senescence in human umbilical vein endothelial cells (HUVECs) and the upregulation of YPEL2 in human atherosclerotic plaques. YPEL2 was significantly upregulated in both H 2 O 2 -induced senescent HUVECs and the arteries of aged mice. Endothelial YPEL2 deficiency significantly decreased H 2 O 2 -increased senescence-associated beta-galactosidase (SA-β-gal) activity and reversed H 2 O 2 -inhibited cell viability. Additionally, endothelial YPEL2 knockdown reduced H 2 O 2 -promoted THP-1 cell adhesion to HUVECs and downregulated ICAM1 and VCAM1 expression. Mechanistic studies divulged that the p53/p21 pathway was involved in YPEL2-induced cellular senescence. We conclude that YPEL2 promotes cellular senescence via the p53/p21 pathway and that YPEL2 expression is elevated in atherosclerosis. These findings reveal YPEL2 as a potential therapeutic target in aging-associated diseases.

本文使用的Yeasen产品

购物车
客服
转染试用